KeyVex › Disclosures › Congressional trades

KeyVex publishes these public financial disclosure filings as news, free and without registration, under the news-media provision of 5 U.S.C. § 13107(c). Source documents are linked on every entry.

Michael D Crapo (Senate) disclosed 1 transaction

· Congressional trades · U.S. Senate Electronic Financial Disclosure / U.S. House Clerk

2017-11-27 · buyPharma Partners, LLC Company: Pharma Partners, LLC (Englewood, CO) Description: The LLC funds research and clinical trials on a new class of drugs, metalloporphyrins. The lead drugs are BMX-010 and BMX-001. — $50,001 - $100,000

The complete record

Every field KeyVex holds for this filing, as its API serves it. Nothing is withheld here that the API sells.

idsenate-8fc0605a-e7b8-49d7-9b29-5177b357907b-1
ownerJoint
partyRepublican
stateID
officeCrapo, Michael D (Senator)
ptr id8fc0605a-e7b8-49d7-9b29-5177b357907b
ticker—
chambersenate
commentInvestment in LLC.
amount max100000
amount min50001
asset namePharma Partners, LLC Company: Pharma Partners, LLC (Englewood, CO) Description: The LLC funds research and clinical trials on a new class of drugs, metalloporphyrins. The lead drugs are BMX-010 and BMX-001.
asset typeOther
report urlhttps://efdsearch.senate.gov/search/view/ptr/8fc0605a-e7b8-49d7-9b29-5177b357907b/
bioguide idC000880
data sourceSENATE_EFD_PTR
member lastCrapo
member nameMichael D Crapo
amount range$50,001 - $100,000
member firstMichael D
state district—
disclosure date2017-12-06
amendment statusoriginal
transaction date2017-11-27
transaction typebuy
reporting lag days6
transaction natureOPEN_MARKET

Original filing document